Home・Stock List・Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc

Closed

0.82 -1.2

Buy Sell

Overview

Share price change

24h

Current

Min

0.83

Max

0.83

Key metrics
By Trading Economics
Income	418K -5.5M
EPS	-0.18
Profit margin	-6,600
Employees	25
EBITDA	906K -5.3M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+376.19% upside

Dividends
By Acuity
Next Earnings	6 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-11M 27M
Previous open	2.02
Previous close	0.82

Actinium Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Aug 2026, 23:51 UTC

Cautious Optimism Surrounds Upcoming South Korea Manufacturing PMI Release Amid Mixed Economic Signals and Regional Trends

2 Aug 2026, 23:51 UTC

Japan's Upcoming Current Account Release on August 9, 2026, Expected to Reflect Export-Import Balance Amidst Cautiously Optimistic Market Sentiment.

2 Aug 2026, 23:51 UTC

Correlated Moves

Macro News

Bitcoin is trading higher, influenced by rising crude oil prices and positive tech stock performance. Ethereum's increase also supports Bitcoin's upward movement today.

2 Aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility and geopolitical tensions, as investors brace for potential Fed rate hikes and key economic data releases.

2 Aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility, while momentum trading strategies face significant drawdowns as the Fed's steady interest rates and geopolitical tensions influence investor sentiment.

2 Aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid geopolitical tensions and potential U.S. rate hikes, as investors brace for key labor market data.

2 Aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid declining momentum trading strategies, while geopolitical tensions and inflation concerns heighten expectations for a potential Federal Reserve interest rate hike.

2 Aug 2026, 23:21 UTC

Social Media

Correlated Moves

Macro News

Geopolitical tensions and rising fuel prices are driving demand for gold. Gold has gained modestly since Friday, with silver also rising today.

2 Aug 2026, 23:02 UTC

Correlated Moves

AUD/CAD is higher in after-market trading, reflecting a modest gain since Friday's close and correlating with a rise in AUD/USD.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/JPY is advancing during Sunday’s session, supported by rising gold prices. The pair remains below its 20-day moving average amid ongoing market volatility.

2 Aug 2026, 23:01 UTC

Correlated Moves

Macro News

EUR/USD rises in after-market trading, reflecting market reactions to potential U.S. monetary policy changes and concerns about a financial crisis linked to AI developments.

2 Aug 2026, 23:01 UTC

Copper is trading higher during Sunday’s session, maintaining strength despite a slight pullback from earlier gains. It remains above its 20-day moving average.

2 Aug 2026, 23:01 UTC

GBP/NOK is trading higher in after-market hours, reflecting a shift in trading dynamics despite recent market volatility and being near the lower end of its one-month range.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver prices are advancing today, reflecting a broader upward movement in precious metals, despite earlier intraday volatility. Gold's increase may support silver's rise.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/NZD is higher today, recovering from an earlier low and reflecting a similar rise in gold prices since Friday's close.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/CHF is trading higher, recovering from earlier lows and reflecting a strong upward trajectory since Friday's close, in line with rising gold prices.

2 Aug 2026, 23:01 UTC

Macro News

The Nikkei 225 Index is lower in after-market hours, continuing a decline linked to a weaker yen and potential interest rate hikes amid inflation concerns.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/GBP is trading higher, recovering from an earlier dip. The asset has increased notably since Friday's close, reflecting a strong correlation with gold.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/CAD is trading higher, rebounding from earlier losses amid rising silver prices. Broader market sentiment shows a decline in momentum trading strategies.

2 Aug 2026, 23:01 UTC

Correlated Moves

The S&P 500 Index is trading higher, continuing a trend of three consecutive positive sessions, supported by gains in the Dow Jones Index.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/JPY is trading higher amid market volatility, reflecting a notable increase. The rise aligns with a gain in gold, indicating a strong correlation.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading higher, reflecting a broader rise in precious metals. Earlier, the asset pulled back but has since rebounded from session lows.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/AUD is rising today, supported by an increase in Gold (XAU/USD). The price remains near the lower end of its one-month trading range.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/CHF is advancing, reflecting gains in Gold (XAU/USD) and macroeconomic factors. Recent market volatility continues to influence investor risk sentiment.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/GBP is trading higher, recovering from an earlier dip amid increased Gold prices and shifts in investor sentiment during market volatility.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/NZD is trading higher, recovering from earlier fluctuations, as gold prices rise. It remains about 1.03% below its 20-day moving average.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver/HKD is trading higher today, supported by a rise in gold prices. Earlier, it experienced notable volatility but has since recovered above Friday's close.

2 Aug 2026, 23:01 UTC

Macro News

The US 5Y Treasury Bond Index is higher, recovering from an early dip amid Federal Reserve discussions on interest rate hikes and inflation concerns.

2 Aug 2026, 23:01 UTC

Correlated Moves

Silver Ounce vs Euro shows notable gains today, driven by rising gold prices. Earlier, XAG/EUR pulled back from a session high but remains elevated.

2 Aug 2026, 23:01 UTC

Correlated Moves

Gold/HKD is higher today, reflecting a modest gain since Friday's close amid broader market volatility and heightened investor anxiety.

Peer Comparison

Price change

Actinium Pharmaceuticals Inc Forecast

Price Target

By TipRanks

376.19% upside

12 Months Forecast

Average 4 USD 376.19%

High 4 USD

Low 4 USD

Based on 1 Wall Street analysts offering 12 month price targets forActinium Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Actinium Pharmaceuticals Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.